Persistent CMV Viremia
1 clinical trials · Condition
◉ Watch Persistent CMV Viremia
| Record | Firm | Date |
|---|---|---|
| Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation (NCT02136797) | Memorial Sloan Kettering Cancer Center | 2014-05-08 |
Track Persistent CMV Viremia automatically
Every clearance here is in the API, with alerts when new ones post.